Mark Strobeck

Mark Strobeck

Chief Executive Officer bei ROCKWELL MEDICAL, INC.

Vermögen: 247 944 $ am 31.03.2024

53 Jahre
Health Technology
Finance
Consumer Services

Profil

Mark Strobeck currently works at Rockwell Medical, Inc., as President, Chief Executive Officer & Director from 2022, Windtree Therapeutics, Inc., as Independent Director from 2023, and Horse Power For Life, as Director from 2012.
Dr. Strobeck also formerly worked at Corridor Pharmaceuticals, Inc., as President & Chief Executive Officer from 2012 to 2013, Novalar Pharmaceuticals, Inc., as Director, Aquilo Partners LP, as Managing Director from 2021 to 2022, Protein Forest, Inc., as Director, Assertio Therapeutics, Inc., as Chief Operating Officer & Executive Vice President in 2020, Standard BioTools, Inc., as Board Observer, Santarus, Inc., as Board Observer, Topaz Pharmaceuticals, Inc., as Chief Business Officer & Vice President from 2010 to 2011, Zyla Life Sciences LLC, as Chief Operating Officer & Executive Vice President from 2015 to 2020, GSK Equity Investments Ltd., as Principal from 2004 to 2006, Mitsubishi Tanabe Pharma Corp., as Principal, KuDOS Pharmaceuticals Ltd., as Board Observer, GlaxoSmithKline, Inc., as Vice President-Business Development from 2003 to 2008, Ben Franklin Technology Partners, as Member, Trevena, Inc., as Chief Business Officer from 2008 to 2010, and Assertio Holdings, Inc., as Chief Operating Officer & Executive Vice President in 2020.
Dr. Strobeck received his doctorate degree in 1999 from the University of Cincinnati (Ohio) and undergraduate degree in 1993 from St. Lawrence University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
17.03.2024 149 364 ( 0,51% ) 247 944 $ 31.03.2024

Aktive Positionen von Mark Strobeck

UnternehmenPositionBeginn
ROCKWELL MEDICAL, INC. Chief Executive Officer 01.07.2022
WINDTREE THERAPEUTICS, INC. Director/Board Member 22.06.2023
Horse Power For Life Director/Board Member 01.01.2012
Alle aktiven Positionen von Mark Strobeck

Ehemalige bekannte Positionen von Mark Strobeck

UnternehmenPositionEnde
Corporate Officer/Principal 01.06.2022
ASSERTIO HOLDINGS, INC. Chief Operating Officer 14.12.2020
Chief Operating Officer 14.12.2020
ZYLA LIFE SCIENCES Chief Operating Officer 20.05.2020
Chief Executive Officer 01.12.2013
Sehen Sie sich die Erfahrung von Mark Strobeck im Detail an

Ausbildung von Mark Strobeck

University of Cincinnati (Ohio) Doctorate Degree
St. Lawrence University Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Mark Strobeck im Detail an

Beziehungen

99

Beziehungen ersten Grades

21

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen5
WINDTREE THERAPEUTICS, INC.

Health Technology

ROCKWELL MEDICAL, INC.

Health Technology

STANDARD BIOTOOLS INC.

Health Technology

TREVENA, INC.

Health Technology

ASSERTIO HOLDINGS, INC.

Health Technology

Private Unternehmen14

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Technology Services

Finance

Health Technology

Horse Power For Life

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Mark Strobeck